Epigenetic-based differentiation therapy for Acute Myeloid Leukemia.
Saved in:
| Title: | Epigenetic-based differentiation therapy for Acute Myeloid Leukemia. |
|---|---|
| Authors: | San José-Enériz E; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain., Gimenez-Camino N; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain., Rabal O; Small-Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, Avenida Pío XII 55, 31008, Pamplona, Spain., Garate L; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain., Miranda E; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain., Gómez-Echarte N; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain., García F; ProteoRed-ISCIII, Unidad de Proteómica, Centro Nacional de Investigaciones Oncológicas (CNIO), Melchor Fernández Almagro 3, 28029, Madrid, Spain., Charalampopoulou S; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Casanova 143, 08036, Barcelona, Spain., Sáez E; Small-Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, Avenida Pío XII 55, 31008, Pamplona, Spain., Vilas-Zornoza A; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain., San Martín-Uriz P; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain., Valcárcel LV; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain.; TECNUN, Universidad de Navarra, Manuel de Lardizábal 13, 20018, San Sebastián, Spain., Barrena N; TECNUN, Universidad de Navarra, Manuel de Lardizábal 13, 20018, San Sebastián, Spain., Alignani D; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain., Tamariz-Amador LE; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain.; Departmento de Hematología, Clínica Universidad de Navarra, and CCUN, Universidad de Navarra, Avenida Pío XII 36, 31008, Pamplona, Spain., Pérez-Ruiz A; Biomedical Engineering Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, Avenida Pío XII 55, 31008, Pamplona, Spain., Hilscher S; Department of Enzymology, Charles Tanford Protein Center, Institute of Biochemistry and Biotechnology, Martin-Luther-University Halle-Wittenberg, 06120, Halle, Germany.; Department of Medicinal Chemistry, Institute of Pharmacy, Martin-Luther-University Halle-Wittenberg, 06120, Halle, Germany., Schutkowski M; Department of Enzymology, Charles Tanford Protein Center, Institute of Biochemistry and Biotechnology, Martin-Luther-University Halle-Wittenberg, 06120, Halle, Germany.; Department of Medicinal Chemistry, Institute of Pharmacy, Martin-Luther-University Halle-Wittenberg, 06120, Halle, Germany., Alfonso-Pierola A; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain.; Departmento de Hematología, Clínica Universidad de Navarra, and CCUN, Universidad de Navarra, Avenida Pío XII 36, 31008, Pamplona, Spain., Martinez-Calle N; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain.; Departmento de Hematología, Clínica Universidad de Navarra, and CCUN, Universidad de Navarra, Avenida Pío XII 36, 31008, Pamplona, Spain., Larrayoz MJ; CIMA LAB Diagnostics, Universidad de Navarra, Avenida Pío XII 55, 31008, Pamplona, Spain., Paiva B; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain., Calasanz MJ; CIMA LAB Diagnostics, Universidad de Navarra, Avenida Pío XII 55, 31008, Pamplona, Spain., Muñoz J; Biocruces Bizkaia Health Research Institute, Cruces Plaza, 48903, Barakaldo, Spain.; Ikerbasque, Basque Foundation for Science, Plaza Euskadi 5, 48009, Bilbao, Spain., Isasa M; ProteoRed-ISCIII, Unidad de Proteómica, Centro Nacional de Investigaciones Oncológicas (CNIO), Melchor Fernández Almagro 3, 28029, Madrid, Spain., Martin-Subero JI; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain.; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Casanova 143, 08036, Barcelona, Spain.; Departamento de Fundamentos Clínicos, Universitat de Barcelona, Casanova 143, 08036, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Passeig de Lluís Companys 23, 08010, Barcelona, Spain., Pineda-Lucena A; Small-Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, Avenida Pío XII 55, 31008, Pamplona, Spain., Oyarzabal J; Small-Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, Avenida Pío XII 55, 31008, Pamplona, Spain. julenoyarzabal@external.unav.es., Agirre X; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain. xaguirre@unav.es.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain. xaguirre@unav.es., Prósper F; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain. fprosper@unav.es.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain. fprosper@unav.es.; Departmento de Hematología, Clínica Universidad de Navarra, and CCUN, Universidad de Navarra, Avenida Pío XII 36, 31008, Pamplona, Spain. fprosper@unav.es. |
| Source: | Nature communications [Nat Commun] 2024 Jul 02; Vol. 15 (1), pp. 5570. Date of Electronic Publication: 2024 Jul 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38956053 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Epigenetic-based differentiation therapy for Acute Myeloid Leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22San+José-Enériz+E%22">San José-Enériz E</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gimenez-Camino+N%22">Gimenez-Camino N</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rabal+O%22">Rabal O</searchLink>; Small-Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, Avenida Pío XII 55, 31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Garate+L%22">Garate L</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Miranda+E%22">Miranda E</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gómez-Echarte+N%22">Gómez-Echarte N</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22García+F%22">García F</searchLink>; ProteoRed-ISCIII, Unidad de Proteómica, Centro Nacional de Investigaciones Oncológicas (CNIO), Melchor Fernández Almagro 3, 28029, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Charalampopoulou+S%22">Charalampopoulou S</searchLink>; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Casanova 143, 08036, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Sáez+E%22">Sáez E</searchLink>; Small-Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, Avenida Pío XII 55, 31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Vilas-Zornoza+A%22">Vilas-Zornoza A</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22San+Martín-Uriz+P%22">San Martín-Uriz P</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Valcárcel+LV%22">Valcárcel LV</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain.; TECNUN, Universidad de Navarra, Manuel de Lardizábal 13, 20018, San Sebastián, Spain.<br /><searchLink fieldCode="AU" term="%22Barrena+N%22">Barrena N</searchLink>; TECNUN, Universidad de Navarra, Manuel de Lardizábal 13, 20018, San Sebastián, Spain.<br /><searchLink fieldCode="AU" term="%22Alignani+D%22">Alignani D</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Tamariz-Amador+LE%22">Tamariz-Amador LE</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain.; Departmento de Hematología, Clínica Universidad de Navarra, and CCUN, Universidad de Navarra, Avenida Pío XII 36, 31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Pérez-Ruiz+A%22">Pérez-Ruiz A</searchLink>; Biomedical Engineering Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, Avenida Pío XII 55, 31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Hilscher+S%22">Hilscher S</searchLink>; Department of Enzymology, Charles Tanford Protein Center, Institute of Biochemistry and Biotechnology, Martin-Luther-University Halle-Wittenberg, 06120, Halle, Germany.; Department of Medicinal Chemistry, Institute of Pharmacy, Martin-Luther-University Halle-Wittenberg, 06120, Halle, Germany.<br /><searchLink fieldCode="AU" term="%22Schutkowski+M%22">Schutkowski M</searchLink>; Department of Enzymology, Charles Tanford Protein Center, Institute of Biochemistry and Biotechnology, Martin-Luther-University Halle-Wittenberg, 06120, Halle, Germany.; Department of Medicinal Chemistry, Institute of Pharmacy, Martin-Luther-University Halle-Wittenberg, 06120, Halle, Germany.<br /><searchLink fieldCode="AU" term="%22Alfonso-Pierola+A%22">Alfonso-Pierola A</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain.; Departmento de Hematología, Clínica Universidad de Navarra, and CCUN, Universidad de Navarra, Avenida Pío XII 36, 31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Martinez-Calle+N%22">Martinez-Calle N</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain.; Departmento de Hematología, Clínica Universidad de Navarra, and CCUN, Universidad de Navarra, Avenida Pío XII 36, 31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Larrayoz+MJ%22">Larrayoz MJ</searchLink>; CIMA LAB Diagnostics, Universidad de Navarra, Avenida Pío XII 55, 31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Paiva+B%22">Paiva B</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Calasanz+MJ%22">Calasanz MJ</searchLink>; CIMA LAB Diagnostics, Universidad de Navarra, Avenida Pío XII 55, 31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Muñoz+J%22">Muñoz J</searchLink>; Biocruces Bizkaia Health Research Institute, Cruces Plaza, 48903, Barakaldo, Spain.; Ikerbasque, Basque Foundation for Science, Plaza Euskadi 5, 48009, Bilbao, Spain.<br /><searchLink fieldCode="AU" term="%22Isasa+M%22">Isasa M</searchLink>; ProteoRed-ISCIII, Unidad de Proteómica, Centro Nacional de Investigaciones Oncológicas (CNIO), Melchor Fernández Almagro 3, 28029, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Martin-Subero+JI%22">Martin-Subero JI</searchLink>; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain.; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Casanova 143, 08036, Barcelona, Spain.; Departamento de Fundamentos Clínicos, Universitat de Barcelona, Casanova 143, 08036, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Passeig de Lluís Companys 23, 08010, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Pineda-Lucena+A%22">Pineda-Lucena A</searchLink>; Small-Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, Avenida Pío XII 55, 31008, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Oyarzabal+J%22">Oyarzabal J</searchLink>; Small-Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, Avenida Pío XII 55, 31008, Pamplona, Spain. julenoyarzabal@external.unav.es.<br /><searchLink fieldCode="AU" term="%22Agirre+X%22">Agirre X</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain. xaguirre@unav.es.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain. xaguirre@unav.es.<br /><searchLink fieldCode="AU" term="%22Prósper+F%22">Prósper F</searchLink>; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Universidad de Navarra, IDISNA, CCUN, Avenida Pío XII 55, 31008, Pamplona, Spain. fprosper@unav.es.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029, Madrid, Spain. fprosper@unav.es.; Departmento de Hematología, Clínica Universidad de Navarra, and CCUN, Universidad de Navarra, Avenida Pío XII 36, 31008, Pamplona, Spain. fprosper@unav.es. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2024 Jul 02; Vol. 15 (1), pp. 5570. <i>Date of Electronic Publication: </i>2024 Jul 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38956053 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-024-49784-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 5570 Titles: – TitleFull: Epigenetic-based differentiation therapy for Acute Myeloid Leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: San José-Enériz E – PersonEntity: Name: NameFull: Gimenez-Camino N – PersonEntity: Name: NameFull: Rabal O – PersonEntity: Name: NameFull: Garate L – PersonEntity: Name: NameFull: Miranda E – PersonEntity: Name: NameFull: Gómez-Echarte N – PersonEntity: Name: NameFull: García F – PersonEntity: Name: NameFull: Charalampopoulou S – PersonEntity: Name: NameFull: Sáez E – PersonEntity: Name: NameFull: Vilas-Zornoza A – PersonEntity: Name: NameFull: San Martín-Uriz P – PersonEntity: Name: NameFull: Valcárcel LV – PersonEntity: Name: NameFull: Barrena N – PersonEntity: Name: NameFull: Alignani D – PersonEntity: Name: NameFull: Tamariz-Amador LE – PersonEntity: Name: NameFull: Pérez-Ruiz A – PersonEntity: Name: NameFull: Hilscher S – PersonEntity: Name: NameFull: Schutkowski M – PersonEntity: Name: NameFull: Alfonso-Pierola A – PersonEntity: Name: NameFull: Martinez-Calle N – PersonEntity: Name: NameFull: Larrayoz MJ – PersonEntity: Name: NameFull: Paiva B – PersonEntity: Name: NameFull: Calasanz MJ – PersonEntity: Name: NameFull: Muñoz J – PersonEntity: Name: NameFull: Isasa M – PersonEntity: Name: NameFull: Martin-Subero JI – PersonEntity: Name: NameFull: Pineda-Lucena A – PersonEntity: Name: NameFull: Oyarzabal J – PersonEntity: Name: NameFull: Agirre X – PersonEntity: Name: NameFull: Prósper F IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 07 Text: 2024 Jul 02 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |